-
CMS needs to improve oversight of Medicare Part B drug payment calculations, OIG report finds
CMS needs better strategies to ensure proper oversight of Medicare Part B drug payment calculations, according to a Dec. 3 report from HHS' Office of the Inspector General. -
New Jersey now requires individual, small business plans to cover abortion care
New Jersey has become the eighth state to require state-regulated health plans to cover abortion services. -
New Mexico proposes health equity-focused Medicaid overhaul: 4 things to know
New Mexico is planning several changes to its Medicaid program, focused on equity and whole-person care. -
Prime Therapeutics joins other PBMs in adding Humira biosimilars
Prime Therapeutics will add Humira biosimilars in the same position in its formulary as the original drug, joining other pharmaceutical benefit managers in announcing similar policies. -
New payer price transparency rules take effect Jan. 1
New requirements for payers under CMS' Transparency in Coverage rule take effect Jan. 1. -
Washington state approved to offer ACA coverage to noncitizens
Washington is the nation's first state to be approved by HHS to offer health and dental ACA coverage to any resident, regardless of immigration status, The Hill reported Dec. 12. -
CMS proposes rule to further overhaul Medicare Advantage marketing, prior authorization
CMS issued a proposed rule Dec. 14 to continue its efforts to overhaul prior authorization and marketing practices around Medicare Advantage and Part D plans, along with adding health equity measures to star ratings and boosting behavioral health network adequacy requirements. -
CMS proposes new rule for ACA plans: 5 things to know
CMS is proposing a new rule to streamline options on the ACA marketplace and add more provider network requirements. -
Bloomberg: It's time to end the public health emergency
The number of powerful voices calling for an end to the nation's COVID-19 public health emergency is growing larger. -
MyChart message fees live on unstable ground
When Cleveland Clinic said it would begin billing for certain Epic MyChart messages this November, it set off a fiery debate across the healthcare industry around hospital finances, patient access and physician burnout. -
Cigna adds Humira biosimilars to formulary
Cigna will add Humira biosimilars to its pharmacy formulary, giving the new, cheaper alternative products hitting the market next year the same position as the drug. -
New Jersey looks to require some payers to cover abortions
New Jersey is likely to soon become the eighth state to require state-regulated health plans to cover abortion services, Bloomberg reported Dec. 1. -
'A disaster scenario': Payers, providers urge Congress to extend HDHP telehealth flexibilities as expiration looms
The Connected Health Initiative, a coalition of medical groups, payers, universities and technology companies, wrote to congressional leaders Nov. 28 urging them to extend telehealth coverage for people with high deductible health plans before they hit their deductible, a policy that expires at the end of this year. -
New ACA customers up nearly 40%
Nearly 3.4 million people have signed up for ACA coverage since the open enrollment period began Nov. 1, or a 17 percent increase in enrollment since last year. -
Bernie Sanders poised to lead Senate health committee
Sen. Bernie Sanders' office said Nov. 17 that he is looking to become chair of the Senate's Health, Education, Labor and Pensions Committee, according to The Hill. -
As payers prep for a PHE wind down, most Medicaid beneficiaries don't know coverage will end
The expiration of the federal COVID-19 public health emergency will trigger a nationwide Medicaid redetermination process, but most Medicaid members are unaware their health coverage could eventually end — and payers largely aren't getting the word out. -
OptumRx will keep Humira available as competitors hit the market
UnitedHealth Group's OptumRx will keep Humira in its drug formulary, in addition to three biosimilar competitors, Bloomberg reported Nov. 15. -
Senate Democrats push for more Medicare Advantage marketing regulations
U.S. Senate Democrats are urging CMS to continue its oversight of Medicare Advantage marketing practices and introduce additional regulations to protect consumers from deceptive tactics. -
Medicare plan finder won't include $35 insulin cap for 2023
Newly capped insulin prices for Medicare beneficiaries at $35 won't show up in Medicare Plan Finder this year. -
HHS to maintain COVID-19 public health emergency past January
The U.S. will extend the COVID-19 public health emergency past January 11, 2023, CNBC reported Nov. 11.
Page 13 of 50